Drug recall · May 8, 2019
HYDROmorphone 20 mg/100 mL Injectable Solution recall
Why: Sub-potency
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, Sterile single use bag, Compounded Drug, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC: 42852-221-10
- Lots / codes
Lot: 01/14/19 0215 22110P Exp. 04/29/2019
- Quantity
- 560 bags
- Company
- Advanced Pharma Inc., Houston, TX
- Distribution
- Nationwide in the US
- Initiated
- April 26, 2019 · Voluntary: Firm initiated
- Classified
- April 29, 2019
- Reported
- May 8, 2019
- Ended
- October 30, 2019
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydromorphone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.